Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Amortizatization of Intangibles (2016)

United Therapeutics' Amortizatization of Intangibles history spans 8 years, with the latest figure at -$100000.0 for Q2 2016.

  • For Q2 2016, Amortizatization of Intangibles rose 75.0% year-over-year to -$100000.0; the TTM value through Jun 2016 reached -$1.0 million, up 71.67%, while the annual FY2015 figure was -$2.1 million, 59.24% up from the prior year.
  • Amortizatization of Intangibles for Q2 2016 was -$100000.0 at United Therapeutics, up from -$200000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at -$100000.0 in Q2 2016 and bottomed at -$1.6 million in Q1 2014.
  • The 5-year median for Amortizatization of Intangibles is -$1.0 million (2013), against an average of -$931555.6.
  • The largest annual shift saw Amortizatization of Intangibles crashed 59.44% in 2014 before it skyrocketed 80.0% in 2016.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$1.3 million in 2012, then fell by 10.3% to -$1.4 million in 2013, then rose by 27.8% to -$1.0 million in 2014, then surged by 74.32% to -$266000.0 in 2015, then skyrocketed by 62.41% to -$100000.0 in 2016.
  • Per Business Quant, the three most recent readings for UTHR's Amortizatization of Intangibles are -$100000.0 (Q2 2016), -$200000.0 (Q1 2016), and -$266000.0 (Q4 2015).